June 5th, 2008

You Talking to Me?

Lured by the promise of a free drink, I joined PharmaMarketing’s John Mack last night for a meal and conversation at a hotel near Princeton. While there, I spoke briefly about JNJBTW. Okay — I’m not going to bore you with a recap of what I said, but I think it is was worth reiterating one blogging “aha” moments that I shared as everyone digested their chicken, flank steak and penne pasta with shrimp.

When I started JNJBTW, I thought my audience would be pretty much those who write about the business of healthcare — reporters, editors, healthcare bloggers — those folks. What I’ve found, after doing this for a year, is that the people reading this are, well, er, people. Doctors, nurses, consumers — employees and retirees — people who hate the company and people who support what we do — friends, neighbors, my father-in-law… well, you get the idea.

Now those who have been blogging for a while may think, “well, duh!?” but for me it was an important point — particularly since I’m often asked “who is your audience?” My answer, which many people scoff at, is that it is everybody — that I don’t define my audience, but that the audience defines itself.

2 Responses to “You Talking to Me?”

  1. Jackie C. says

    Count me among the regular Joes and Janes (ok, somewhat regular – I’m in the PR biz) reading this blog on a very frequent basis.

    Without hesitation, I would say JNJ BTW is the best example of how a corporation can use a blog to engage their constituencies in a meaningful, productive, less mediated way.

    Really well done, folks. My hat’s off to ya!

  2. John Mack says


    Thanks for showing up at my networking event and sharing your thoughts about JNJBTW. I think your presentation was of most interest to attendees, 72% of whom rated the content “Excellent” or “Very Good.”


Leave a Reply

All comments will be reviewed before posting. Since this blog is about Johnson & Johnson, comments that don’t directly relate to the Company or to topics covered on this blog won’t be posted. Please see our comments policy for details.